---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026529"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-06-01T11:30:18+00:00"
generated_at: "2026-06-01T11:35:44.012401+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nasdaq panel grants HCW Biologics extension to July 29, 2026 to regain $1 bid price compliance

## Summary
- Must demonstrate bid price at or above $1 for 20 consecutive trading days by July 29, 2026.
- If deficient before September 22, 2026, Company will be immediately delisted.
- Non-compliance with any other listing rule before Sep 22 gives 7 days to advise panel.
- Regaining compliance will result in a Discretionary Panel Monitor for one year.
- Company's hearing was on May 5, 2026; panel granted extension on May 29, 2026.

## SEC filing metadata
- accession: 0001493152-26-026529
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-06-01T11:30:18+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/0001493152-26-026529-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026529
- JSON: https://secwatch.observer/filing/0001493152-26-026529.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026529.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.